Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Tumor recurrence after complete resection for non-small cell lung cancer
Matthew D. Taylor
, Alykhan S. Nagji
, Castigliano M. Bhamidipati
, Nicholas Theodosakis
,
Benjamin D. Kozower
, Christine L. Lau
, David R. Jones
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Section of Thoracic Surgery
Research output
:
Contribution to journal
›
Article
›
peer-review
192
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Tumor recurrence after complete resection for non-small cell lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Tumor Recurrence
100%
Gross Total Resection
100%
Hazard Ratio
85%
Resection
57%
Recurrence Hazard
42%
SUVmax
28%
Lymphovascular Invasion
28%
Preoperative Radiation
28%
Pathological Stage
28%
Distant Recurrence
28%
Locoregional Recurrence
28%
Sublobar Resection
28%
Lung Cancer Recurrence
28%
Inclusion Criteria
14%
Tumor
14%
Pathologic
14%
Long-term Survival
14%
Large Series
14%
Single Institution
14%
Standardized Uptake Value
14%
Recurrence Rate
14%
Subgroup Analysis
14%
R0 Resection
14%
Recurrence Risk
14%
Stage III Disease
14%
Primary Cancer
14%
Disease Stage
14%
Hazard Model
14%
Cox Proportional Regression
14%
Complete Surgical Resection
14%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Recurrent Disease
100%
Tumor Recurrence
100%
Hazard Ratio
60%
Preoperative Radiotherapy
20%
Cancer Recurrence
20%
Lymphovascular Invasion
20%
Neoplasm
10%
Primary Tumor
10%
Proportional Hazards Model
10%
Long Term Survival
10%
Standardized Uptake Value
10%
Subgroup Analysis
10%
Diseases
10%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Recurrent Disease
100%
Tumor Recurrence
100%
Cancer Recurrence
20%
Lymph Vessel Metastasis
20%
Neoplasm
10%
Primary Tumor
10%
Long Term Survival
10%
Diseases
10%